Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis

dc.contributor.authorKhanna, Dinesh
dc.contributor.authorKramer, Frank
dc.contributor.authorHöfler, Josef
dc.contributor.authorGhadessi, Mercedeh
dc.contributor.authorSandner, Peter
dc.contributor.authorAllanore, Yannick
dc.contributor.authorDenton, Christopher
dc.contributor.authorKuwana, Masataka
dc.contributor.authorMatucci-Cerinic, Marco
dc.contributor.authorPope, Janet
dc.contributor.authorAtsumi, Tatsuya
dc.contributor.authorBecvar, Radim
dc.contributor.authorCzirják, László
dc.contributor.authorLanghe, Ellen De
dc.contributor.authorHachulla, Eric
dc.contributor.authorIshii, Tomonori
dc.contributor.authorIshikawa, Osamu
dc.contributor.authorJohnson, Sindhu R.
dc.contributor.authorRiccieri, Valeria
dc.contributor.authorSchiopu, Elena
dc.contributor.authorSilver, Richard
dc.contributor.authorSmith, Vanessa
dc.contributor.authorStagnaro, Chiara
dc.contributor.authorSteen, Virginia
dc.contributor.authorStevens, Wendy
dc.contributor.authorSzűcs, Gabriella
dc.contributor.authorTruchetet, Marie-Elise
dc.contributor.authorWosnitza, Melanie
dc.contributor.authorDistler, Oliver
dc.date.accessioned2024-04-15T14:43:40Z
dc.date.available2024-04-15T14:43:40Z
dc.date.issued2024
dc.date.oa2024-04-25
dc.date.pasync2024-04-25T23:06:54Z
dc.date.updated2024-04-15T14:43:40Z
dc.description.correctorkzs
dc.identifier.citationRheumatology. -[Epub ahead of print] (2024). -RHEUMATOLOGY. - 1462-0324. - 1462-0332
dc.identifier.doihttp://dx.doi.org/10.1093/rheumatology/keae150
dc.identifier.issn1462-0332
dc.identifier.issn1462-0324
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM120451
dc.identifier.urihttps://hdl.handle.net/2437/368814
dc.identifier.urlhttps://academic.oup.com/rheumatology/advance-article/doi/10.1093/rheumatology/keae150/7625109
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleBiomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 2 (Összesen 2)
Nem elérhető
Név:
FILE_UP_0_Khanna SSc riociguate.pdf
Méret:
1.29 MB
Formátum:
Adobe Portable Document Format
Nem elérhető
Név:
keae150.pdf
Méret:
1.16 MB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat